$XRP
After the SEC Settlement: Boom or Bust?
Ripple has reached a $50M settlement with the SEC, ending a long-standing legal battle over XRP’s institutional sales.
In a bold move, Ripple also invested $50M in Wellgistics, aiming to integrate XRP-based real-time payments into U.S. pharmaceutical logistics.
While the deal caused a brief stock spike, Wellgistics shares soon dropped. Meanwhile, a lobbying scandal erupted after a Trump-linked post promoted XRP for a U.S. crypto reserve, sparking controversy.
Ripple’s latest steps may signal a broader push for blockchain in healthcare and payments.
Will you invest in XRP now or miss out again?
